Silver Book Fact

Cytokines in urine are associated with age-related macular degeneration (AMD) and could be developed as a biomarker and provide a practical tool for early detection

Guymer, Robyn H. Lingwui W. Tao, Jonathan K. Goh, Danny Liew, Olga Ischenko, Liubov D. Robman, KhinZaw Aung, Tania Cipriani, Melinda Cain, Andrea J. Richardson, Paul N. Baird, and Robyn Langham. Identification of Urine Biomarkers for AMD. Invest Opthalmol Vis Sci. 2011; 52(7): 4639-4644

Reference

Title
Identification of Urine Biomarkers for AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Guymer, Robyn H. Lingwui W. Tao, Jonathan K. Goh, Danny Liew, Olga Ischenko, Liubov D. Robman, KhinZaw Aung, Tania Cipriani, Melinda Cain, Andrea J. Richardson, Paul N. Baird, and Robyn Langham
Volume & Issue
Volume 52, Issue 7
Pages
4639-4644

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Laser treatment and vitrectomy reduce the risk of blindness in patients with severe diabetic retinopathy by 90%.  
  • After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration…  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.